Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: ANEON BRILLIENT, LLC
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2024-08-22 to 2025-08-29
Current total value of award: $192142.38
Description: CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF PHARMACEUTICAL QUALITY (OPQ), QUALITY ASSURANCE SPECIALIST III